Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Social Anxiety Disorder
NCT05823753Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in Social Anxiety Disorder (SAD) (3 arms), sponsored by University of California, San Diego. Primary endpoints: Plasma Anandamide Levels at Day 4 and Subjective Units of Distress Scale at Day 4. Started Apr 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05823753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823753.